Springer Nature’s Success Boosts European Equity Capital Markets Amidst Lagging U.S. Performance

  • Springer Nature’s shares rose 9.6% on debut, boosting Europe’s IPO market
  • Total IPO proceeds in Europe increased by 41% to $15.4 billion in the first three quarters of this year
  • U.S. IPO proceeds grew 40% to $27.3 billion during the same period
  • European deals down 12% compared to U.S. listings
  • Largest European IPO so far in 2021: Lineage at $4.4 billion
  • UK’s Raspberry Pi and Spain’s Europastry preparing for IPOs
  • Mature tech startups like Vinted, Zilch, and Klarna considering listings

The European initial public offering (IPO) market has shown signs of recovery, with Springer Nature’s shares rising by 9.6% on its debut in Frankfurt. This comes after a period of depressed levels for IPO proceeds last year. The total funds raised by new listings grew by 41% to $15.4 billion in the first three quarters, compared to a 40% increase to $27.3 billion in the U.S., according to EY’s recent report. Despite this progress, European deals are still lagging behind the U.S. with only 94 companies listed, down 12% from last year’s 130 listings. The UK’s Raspberry Pi and Spain’s Europastry are among those preparing for IPOs, while mature tech startups like Vinted, Zilch, and Klarna consider their listing options. Experts predict a positive outlook for the rest of the year as Europe makes its markets more attractive to investors.

Factuality Level: 8
Factuality Justification: The article provides accurate information about Springer Nature’s IPO performance and discusses the overall state of European IPO market compared to the U.S. It includes quotes from experts in the field and cites relevant data sources. However, it contains some speculation about future market trends and unconfirmed plans for other companies going public.
Noise Level: 6
Noise Justification: The article provides some relevant information about the performance of Springer Nature’s IPO and the overall trend of European IPOs, but it also contains some irrelevant details such as mentioning unrelated companies like Jean Paul Gaultier and Raspberry Pi. Additionally, there is a focus on speculation about future events like the outcome of the U.S. presidential election and the potential listing locations for other companies. The article could benefit from more focus on the main topic and less on peripheral information.
Public Companies: Springer Nature (not available), Pentixapharm (not available), Puig (PUIG), Lineage (not available), Galderma Group (not available), Raspberry Pi (not available), Vinted (not available), Zilch (not available), Klarna (not available)
Private Companies: CVC Capital Partners,Europastry,Shein
Key People: Martin Steinbach (EY’s IPO leader for Europe, the Middle East, India and Africa), Brian Hanratty (head of equity capital markets at Peel Hunt)

Track all markets on TradingView

Financial Relevance: Yes
Financial Markets Impacted: Yes
Financial Rating Justification: The article discusses the rise in shares of Springer Nature, impacting financial markets and companies. It also mentions the increase in funds raised by new listings in Europe and the U.S., as well as the outlook for future IPOs in both regions.
Presence Of Extreme Event: No
Nature Of Extreme Event: Other
Impact Rating Of The Extreme Event: Minor
Extreme Rating Justification: There is no extreme event mentioned in the article. The main topic discusses the positive performance of Springer Nature’s IPO and the revival of European equity capital markets.
Move Size: 9.6%
Sector: Technology
Direction: Up
Magnitude: Medium
Affected Instruments: Stocks

Reported publicly: www.wsj.com